Latest News about GKOS
Recent news which mentions GKOS
From Benzinga
From Benzinga
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
February 24, 2025
From Benzinga
Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?
February 21, 2025
From Benzinga
Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition
February 21, 2025
From Benzinga
Earnings Scheduled For February 20, 2025
February 20, 2025
From Benzinga
From Benzinga
$1000 Invested In Glaukos 5 Years Ago Would Be Worth This Much Today
January 23, 2025
From Benzinga
Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market
January 13, 2025
From Benzinga
From Benzinga
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 06, 2024
From Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December 02, 2024
From Benzinga
From Benzinga
Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds
November 05, 2024
From Benzinga
From Benzinga
Tickers
GKOS
From InvestorPlace
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
